- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Captor Therapeutics SA (CTXP)
Captor Therapeutics SA stock price live, this page displays WA CTXP stock exchange data. View the CTXP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Captor Therapeutics SA real time stock price chart below.
What Is the Captor Therapeutics SA Stock Price Today?
The Captor Therapeutics SA stock price today is 40.50.
What Is the Stock Symbol for Captor Therapeutics SA?
The stock symbol for Captor Therapeutics SA is ""CTXP.""
What Stock Exchange Does Captor Therapeutics SA Trade On?
Captor Therapeutics SA is listed and trades on the Warsaw stock exchange.
Is Captor Therapeutics SA a Good Stock to Buy?
Determining whether Captor Therapeutics SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTXP quote. (ISIN: PLCPTRT00014)
What Is the Captor Therapeutics SA Stock Price Today?
The Captor Therapeutics SA stock price today is 40.50.
What Is the Stock Symbol for Captor Therapeutics SA?
The stock symbol for Captor Therapeutics SA is ""CTXP.""
What Stock Exchange Does Captor Therapeutics SA Trade On?
Captor Therapeutics SA is listed and trades on the Warsaw stock exchange.
Is Captor Therapeutics SA a Good Stock to Buy?
Determining whether Captor Therapeutics SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTXP quote. (ISIN: PLCPTRT00014)
Warsaw
Currency in PLN
40.50
-1.60(-3.80%)
Closed·
Fair Value
An estimate of a Captor Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.50
42.10
52 wk Range
31.20
84.00
CTXP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CTXP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Captor Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.5042.10
52 wk Range
31.2084.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CTXP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Captor Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
99.47
Upside
+145.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Captor Therapeutics SA Company Profile
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Compare CTXP to Peers and Sector
Metrics to compare | CTXP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCTXPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.9x | −6.7x | −0.5x | |
PEG Ratio | −0.14 | 0.00 | 0.00 | |
Price/Book | 4.3x | 2.8x | 2.6x | |
Price / LTM Sales | 16.7x | 10.5x | 3.3x | |
Upside (Analyst Target) | 192.1% | 46.8% | 43.5% | |
Fair Value Upside | Unlock | 4.2% | 6.9% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 99.47
(+145.60% Upside)
Earnings
Latest Release
Jun 03, 2025
EPS / Forecast
-1.95 / --
Revenue / Forecast
3.10M / --
People Also Watch
FAQ
What Stock Exchange Does Captor Therapeutics Trade On?
Captor Therapeutics is listed and trades on the Warsaw Stock Exchange stock exchange.
What Is the Stock Symbol for Captor Therapeutics?
The stock symbol for Captor Therapeutics is "CTXP."
What Is the Captor Therapeutics Market Cap?
As of today, Captor Therapeutics market cap is 232.76M.
What Is Captor Therapeutics's Earnings Per Share (TTM)?
The Captor Therapeutics EPS (TTM) is -8.15.
When Is the Next Captor Therapeutics Earnings Date?
Captor Therapeutics will release its next earnings report on 10 Sept 2025.
From a Technical Analysis Perspective, Is CTXP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Captor Therapeutics Stock Split?
Captor Therapeutics has split 0 times.
How Many Employees Does Captor Therapeutics Have?
Captor Therapeutics has 91 employees.
What is the current trading status of Captor Therapeutics (CTXP)?
As of 07 Aug 2025, Captor Therapeutics (CTXP) is trading at a price of 40.50, with a previous close of 42.10. The stock has fluctuated within a day range of 40.50 to 42.10, while its 52-week range spans from 31.20 to 84.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.